[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 390
Citations 0
Research Letter
April 2016

Addition of Statins to Treatment With β-Blockers to Improve Outcomes for Cardiac Surgery PatientsBeyond the Surgical Care Improvement Project

Author Affiliations
  • 1Division of Cardiac Surgery, David Geffen School of Medicine at University of California, Los Angeles
JAMA Surg. 2016;151(4):389-391. doi:10.1001/jamasurg.2015.4212

For nearly 2 decades, β-blockers have been thought to reduce the risk of major adverse cardiovascular events during the perioperative period. Beginning with the Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography trial1 in 1999, a series of studies have provided compelling evidence that patients undergoing high-risk operations should receive β-blockers before surgery.2 Given these findings, the Surgical Care Improvement Project required that all patients previously receiving β-blockers should receive their medication in the 24 hours before surgery. More recently, however, several large-scale studies have failed to reproduce these beneficial effects,3,4 and the Perioperative Ischemic Evaluation trial4 found increased mortality with the use of β-blockers before surgery.

First Page Preview View Large
First page PDF preview
First page PDF preview